Clare A. Balendran

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

Naim Alkhouri, Robert Herring, Heidi Kabler et al. · Journal of Hepatology · 2022 · 193 citations

Identification of the human ApoAV gene as a novel RORα target gene

Ulrika Lind, Tina Nilsson, Jane McPheat et al. · Biochemical and Biophysical Research Communications · 2005 · 28 citations

Molecular Virology, Genetics, Immunology +6

Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor

Hans Ericsson, Karin Nelander, Maria Lagerström‐Fermér et al. · Clinical and Translational Science · 2018 · 22 citations · Full text

Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies

Kevin J. Randall, Neil Henderson, Jaimini Reens et al. · PLoS ONE · 2016 · 20 citations · Full text

Inflammation, Autoimmune Disease, Mucosal Immunology +12

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies

Clare A. Balendran, Ann Lövgren, Kenny M. Hansson et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2017 · 18 citations · Full text